miserotoxin: toxin from Emory milkvetch; measured by nitro moiety
miserotoxin : A beta-D-glucoside having 3-nitropropyl as the anomeric alkyl group.
ID Source | ID |
---|---|
PubMed CID | 107795 |
CHEBI ID | 6951 |
MeSH ID | M0074873 |
Synonym |
---|
glucopyranoside, 3-nitropropyl-, beta-d- |
3-nitropropyl-beta-d-glucopyranoside |
3-nitropropyl beta-d-glucopyranoside |
3-nitro-1-propyl-beta-d-glucoside |
beta-d-glucopyranoside, 3-nitropropyl- |
CHEBI:6951 |
C08507 |
24502-76-9 |
miserotoxin |
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-(3-nitropropoxy)oxane-3,4,5-triol |
0j55bw984l , |
unii-0j55bw984l |
.beta.-d-glucopyranoside, 3-nitropropyl |
Q27107373 |
DTXSID50947395 |
3-nitropropyl hexopyranoside |
Miserotoxin is a causative agent in cattle poisoning when timber milkvetch (Astragalus miser) is consumed.
Excerpt | Reference | Relevance |
---|---|---|
"Miserotoxin is a causative agent in cattle poisoning when timber milkvetch (Astragalus miser) is consumed." | ( Excretion of miserotoxin and detoxification of the aglycone by grasshoppers (Orthoptera: Acrididae). Benn, MH; Johnson, DL; Majak, W, 2001) | 1.4 |
Excerpt | Relevance | Reference |
---|---|---|
" (Leguminosae), was rapidly hydrolyzed to 3-nitropropanol (NPOH) in the rumen of cattle dosed with timber milkvetch (A." | ( Absorption of 3-nitropropanol (miserotoxin aglycone) from the compound stomach of cattle. Majak, W; Muir, AD; Pass, MA; Rode, LM, 1984) | 0.55 |
Role | Description |
---|---|
phytotoxin | Any toxin produced by a plant. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
beta-D-glucoside | Any D-glucoside in which the anomeric centre has beta-configuration. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.96) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (10.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (90.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |